November 15, 2021 Regulatory LIDDS Announces Appointment of Johan Harmenberg as Chief Medical Officer
October 4, 2021 Regulatory NanoZolid®-formulated Docetaxel is Safe and Tolerable Showing Signs of Clinical Efficacy
June 2, 2021 Regulatory LIDDS carry out a directed share issue of and is provided with approximately MSEK 45
June 1, 2021 Regulatory LIDDS Announces Appointment of Jenni Björnulfson as New Chief Financial Officer
March 2, 2021 Regulatory LIDDS enters R&D agreement with potential exclusive, global product license option